Will NVIDIA Return to Its 52-Week High?
NVIDIA (NASDAQ:NVDA) has been among the best-performing investments of the…
Sell
27
BPMC Quote, Financials, Valuation and Earnings
Last price:
$80.79
Seasonality move
:
7.42%
Day range:
$77.63 - $81.28
52-week range:
$73.04 - $121.90
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
10.07x
P/B ratio:
17.30x
Volume:
1.6M
Avg. volume:
1.2M
1-year change:
-12.37%
Market cap:
$5.2B
Revenue:
$508.8M
EPS (TTM):
-$1.08
BPMC Analysts' Consensus Rating
The 16 analysts providing 12-month price projections for Blueprint Medicines shares anticipate an average target of $125.00, ranging from a low estimate of $83.00 to a high estimate of $169.00. This average target implies a growth of 54.63% compared to the current stock price of $80.84.
Consensus Price Target
$125.00
Highest Price Target
$169.00
Lowest Price Target
$83.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 9 | 9 | 10 |
| Hold | 5 | 5 | 5 |
| Sell | 1 | 1 | 1 |
| Consensus | Buy | Buy | Buy |
BPMC Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will JP Morgan’s AI Advisor Be a Winner?
JPMorgan Chase is rolling out “JPM WealthAI for high-net-worth clients.…
Is Revolve Group Stock a Buy, Sell or Hold?
Recently, Revolve Group (NYSE:RVLV) management delivered some fairly positive business…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
52
RGC alert for Apr 12
Regencell Bioscience Holdings [RGC] is up 29.14% over the past day.
Buy
52
SLP alert for Apr 12
Simulations Plus [SLP] is up 26.73% over the past day.
Buy
89
GDXU alert for Apr 12
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.
